Mainstream

Travere Therapeutics Non-GAAP EPS of -$0.47 misses by $0.09, revenue of $74.79M beats by $2.41M

Travere Therapeutics Non-GAAP EPS of -$0.47 misses by $0.09, revenue of $74.79M beats by $2.41M

Post ContenttvtxRead More

You might also be interested in reading FlexShares Credit-Scored US Long Corporate Bond Index Fund declares monthly distribution of $0.2022.

February 20, 2025
In Mainstream